TipRanks
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market
APUS
Apimeds Pharmaceuticals US, Inc.
RESEARCH TOOLSreports

Apimeds Pharmaceuticals US, Inc. (APUS) Cash flow

24 Followers

Apimeds Pharmaceuticals US, Inc. Cash Flow

APUS's free cash flow for Q2 2026 was $-6.18M. For the 2026 fiscal year, APUS's free cash flow was decreased by $-8.25M and operating cash flow was $-6.18M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -8.93M$ -733.53K$ -627.79K$ -448.17K$ -823.11K
Investing Cash Flow
$ -10.06M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 20.62M$ 326.50K$ 1.03M$ 282.90K$ 400.00K
End Cash Position
$ 9.64M$ 3.46K$ 410.48K$ 6.17K$ 171.44K
Free Cash Flow
$ -8.98M$ -733.53K$ -627.79K$ -448.17K$ -823.11K
Currency in USD

Apimeds Pharmaceuticals US, Inc. Cash Flow